Lv79
3480 积分 2024-03-15 加入
Additivity predicts the efficacy of most approved combination therapies for advanced cancer
3天前
已完结
The next generation of antibody–drug conjugates
3天前
已完结
The role of the transferrin–transferrin-receptor system in drug delivery and targeting
5天前
已完结
Comparative Radiotracing Quantifies Brain Cellular Uptake and Catabolism of Bispecific Antibodies Targeting Transferrin Receptor and CD98hc
12天前
已完结
An anti-CD98 antibody displaying pH-dependent Fc-mediated tumour-specific activity against multiple cancers in CD98-humanized mice
12天前
已完结
Brain delivery of therapeutic proteins using an Fc fragment blood-brain barrier transport vehicle in mice and monkeys
13天前
已完结
Strategies for delivering therapeutics across the blood–brain barrier
13天前
已完结
Phase I study of MSB2311, a novel pH-dependent anti-PD-L1 monoclonal antibody, treating patients with advanced solid tumors and lymphoma
13天前
已完结
Cross-priming underlies the efficacy of antibody-drug conjugates and immunotherapy combinations
15天前
已完结
Recent advances in function-enhanced antibody-drug conjugates: Antibody optimization and payload combination
21天前
已完结
皖公网安备34019202002308
